| Name | Title | Contact Details |
|---|
Lyons Lavey Nickel Swift is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Regional Brain Institute is a physician owned practice group that provides intensely patient focused care in affiliation with regional, metropolitan, rural, and Indian Nation healthcare organizations.
Merit Health Systems is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Aquor Health Care Svc is a Woodbridge, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.